With €1.7B in savings in the bank, Sanofi pumps up its cost-cutting target by €500M esagonowsky Fri, 02/05/2021 […]

Gilead sees a blockbuster 2021 for COVID-19 drug Veklury but can grow without it: CFO esagonowsky Fri, 02/05/2021 […]

All eyes on Regeneron’s COVID-19 antibodies, but Dupixent’s still driving the bus bbulik Fri, 02/05/2021 – 11:13

Moderna sets sights on $200M vaccine factory in Seoul: report fkansteiner Fri, 02/05/2021 – 11:46

A new neural network developed by researchers at the University of Eastern Finland and Kuopio University Hospital enables […]

A new online dashboard, created by NYU Professor Alexej Jerschow, brings together COVID-19 data from U.S. states and […]

Most women in the UK aged over 65 years have never had a test for human papillomavirus (HPV). […]

Phase III BE VIVID and BE READY studies both met their co-primary endpoints

Proposals include changes to NICE’s Highly Specialised Technologies programme

Jab recently demonstrated 89.3% efficacy in UK trial